TriangleFOR PATIENTS · SOURCE READING
Immunotherapy
Source: Childhood Soft Tissue Sarcoma (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 9, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Types of treatment for childhood soft tissue sarcoma
Immunotherapy is a treatment that uses the person's immune system to fight cancer. Pembrolizumab may be used to treat undifferentiated pleomorphic sarcoma (malignant fibrous histiocytoma) and progressive and recurrent soft tissue sarcoma.
Learn more about Immunotherapy to Treat Cancer.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice